Literature DB >> 23086103

Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia.

Sten-Eirik W Jacobsen1,2, Tariq Enver3, Christoph Lutz3, Petter S Woll1,2, Georgina Hall4, Anders Castor5, Helene Dreau6, Giovanni Cazzaniga7, Jan Zuna8, Christina Jensen3, Sally A Clark1,2, Andrea Biondi7, Chris Mitchell4, Helen Ferry1,2, Anna Schuh6, Veronica Buckle1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23086103      PMCID： PMC4693965          DOI： 10.1038/leu.2012.306

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia.

Authors:  T Flohr; A Schrauder; G Cazzaniga; R Panzer-Grümayer; V van der Velden; S Fischer; M Stanulla; G Basso; F K Niggli; B W Schäfer; R Sutton; R Koehler; M Zimmermann; M G Valsecchi; H Gadner; G Masera; M Schrappe; J J M van Dongen; A Biondi; C R Bartram
Journal:  Leukemia       Date:  2008-01-31       Impact factor: 11.528

2.  Childhood leukemia: cooperative Berlin-Frankfurt-Münster trials in the Federal Republic of Germany.

Authors:  J Ritter; U Creutzig; A Reiter; H Riehm; G Schellong
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

Review 3.  Minimal residual disease in leukaemia patients.

Authors:  T Szczepański; A Orfão; V H van der Velden; J F San Miguel; J J van Dongen
Journal:  Lancet Oncol       Date:  2001-07       Impact factor: 41.316

4.  Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.

Authors:  Anders Castor; Lars Nilsson; Ingbritt Astrand-Grundström; Miranda Buitenhuis; Carole Ramirez; Kristina Anderson; Bodil Strömbeck; Stanislaw Garwicz; Albert N Békássy; Kjeld Schmiegelow; Birgitte Lausen; Peter Hokland; Sören Lehmann; Gunnar Juliusson; Bertil Johansson; Sten Eirik W Jacobsen
Journal:  Nat Med       Date:  2005-05-22       Impact factor: 53.440

5.  Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.

Authors:  Dengli Hong; Rajeev Gupta; Philip Ancliff; Ann Atzberger; John Brown; Shamit Soneji; Joanne Green; Sue Colman; Wanda Piacibello; Veronica Buckle; Shinobu Tsuzuki; Mel Greaves; Tariq Enver
Journal:  Science       Date:  2008-01-18       Impact factor: 47.728

6.  IFNalpha activates dormant haematopoietic stem cells in vivo.

Authors:  Marieke A G Essers; Sandra Offner; William E Blanco-Bose; Zoe Waibler; Ulrich Kalinke; Michel A Duchosal; Andreas Trumpp
Journal:  Nature       Date:  2009-02-11       Impact factor: 49.962

Review 7.  Acute lymphoblastic leukaemia.

Authors:  Ching-Hon Pui; Leslie L Robison; A Thomas Look
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321

8.  Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

Authors:  J J van Dongen; T Seriu; E R Panzer-Grümayer; A Biondi; M J Pongers-Willemse; L Corral; F Stolz; M Schrappe; G Masera; W A Kamps; H Gadner; E R van Wering; W D Ludwig; G Basso; M A de Bruijn; G Cazzaniga; K Hettinger; A van der Does-van den Berg; W C Hop; H Riehm; C R Bartram
Journal:  Lancet       Date:  1998-11-28       Impact factor: 79.321

9.  In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.

Authors:  Christoph le Viseur; Marc Hotfilder; Simon Bomken; Kerrie Wilson; Silja Röttgers; André Schrauder; Annegret Rosemann; Julie Irving; Ronald W Stam; Leonard D Shultz; Jochen Harbott; Heribert Jürgens; Martin Schrappe; Rob Pieters; Josef Vormoor
Journal:  Cancer Cell       Date:  2008-07-08       Impact factor: 31.743

10.  Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

Authors:  D G Tubergen; G S Gilchrist; R T O'Brien; P F Coccia; H N Sather; M J Waskerwitz; G D Hammond
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544
View more
  15 in total

1.  Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGFA.

Authors:  Itaru Kato; Yoko Nishinaka; Masahiro Nakamura; Ayse U Akarca; Akira Niwa; Hiroki Ozawa; Kenichi Yoshida; Makiko Mori; Dapeng Wang; Makiko Morita; Hiroo Ueno; Yusuke Shiozawa; Yuichi Shiraishi; Satoru Miyano; Rajeev Gupta; Katsutsugu Umeda; Kenichiro Watanabe; Katsuyoshi Koh; Souichi Adachi; Toshio Heike; Megumu K Saito; Masashi Sanada; Seishi Ogawa; Teresa Marafioti; Akira Watanabe; Tatsutoshi Nakahata; Tariq Enver
Journal:  Blood       Date:  2017-04-19       Impact factor: 22.113

2.  A structured population model of clonal selection in acute leukemias with multiple maturation stages.

Authors:  Tommaso Lorenzi; Anna Marciniak-Czochra; Thomas Stiehl
Journal:  J Math Biol       Date:  2019-07-26       Impact factor: 2.259

3.  DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3.

Authors:  Rahul S Bhansali; Malini Rammohan; Paul Lee; Anouchka P Laurent; Qiang Wen; Praveen Suraneni; Bon Ham Yip; Yi-Chien Tsai; Silvia Jenni; Beat Bornhauser; Aurélie Siret; Corinne Fruit; Alexandra Pacheco-Benichou; Ethan Harris; Thierry Besson; Benjamin J Thompson; Young Ah Goo; Nobuko Hijiya; Maria Vilenchik; Shai Izraeli; Jean-Pierre Bourquin; Sébastien Malinge; John D Crispino
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

4.  Elucidating minimal residual disease of paediatric B-cell acute lymphoblastic leukaemia by single-cell analysis.

Authors:  Yingchi Zhang; Shicheng Wang; Jingliao Zhang; Chao Liu; Xinqi Li; Wenbo Guo; Yongjuan Duan; Xiaoyan Chen; Suyu Zong; Jiarui Zheng; Yixuan Wu; Xiaoli Chen; Xuelian Cheng; Yanxia Chang; Yue Wang; Feng Ding; Wenyu Yang; Xiaojuan Chen; Ye Guo; Li Zhang; Yumei Chen; Yao Zou; Xiaofan Zhu; Jin Gu; Tao Cheng
Journal:  Nat Cell Biol       Date:  2022-02-10       Impact factor: 28.213

Review 5.  A rare subgroup of leukemia stem cells harbors relapse-inducing potential in acute lymphoblastic leukemia.

Authors:  Daniela Senft; Irmela Jeremias
Journal:  Exp Hematol       Date:  2018-09-24       Impact factor: 3.084

6.  Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells.

Authors:  Margaret Nieborowska-Skorska; Katherine Sullivan; Yashodhara Dasgupta; Paulina Podszywalow-Bartnicka; Grazyna Hoser; Silvia Maifrede; Esteban Martinez; Daniela Di Marcantonio; Elisabeth Bolton-Gillespie; Kimberly Cramer-Morales; Jaewong Lee; Min Li; Artur Slupianek; Daniel Gritsyuk; Sabine Cerny-Reiterer; Ilona Seferynska; Tomasz Stoklosa; Lars Bullinger; Huaqing Zhao; Vera Gorbunova; Katarzyna Piwocka; Peter Valent; Curt I Civin; Markus Muschen; John E Dick; Jean Cy Wang; Smita Bhatia; Ravi Bhatia; Kolja Eppert; Mark D Minden; Stephen M Sykes; Tomasz Skorski
Journal:  J Clin Invest       Date:  2017-05-08       Impact factor: 14.808

7.  Protracted dormancy of pre-leukemic stem cells.

Authors:  A M Ford; M B Mansur; C L Furness; F W van Delft; J Okamura; T Suzuki; H Kobayashi; Y Kaneko; M Greaves
Journal:  Leukemia       Date:  2015-05-28       Impact factor: 11.528

8.  Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia.

Authors:  Sarah Ebinger; Erbey Ziya Özdemir; Christoph Ziegenhain; Sebastian Tiedt; Catarina Castro Alves; Michaela Grunert; Michael Dworzak; Christoph Lutz; Virginia A Turati; Tariq Enver; Hans-Peter Horny; Karl Sotlar; Swati Parekh; Karsten Spiekermann; Wolfgang Hiddemann; Aloys Schepers; Bernhard Polzer; Stefan Kirsch; Martin Hoffmann; Bettina Knapp; Jan Hasenauer; Heike Pfeifer; Renate Panzer-Grümayer; Wolfgang Enard; Olivier Gires; Irmela Jeremias
Journal:  Cancer Cell       Date:  2016-12-01       Impact factor: 31.743

9.  Mass concentration in a nonlocal model of clonal selection.

Authors:  J-E Busse; P Gwiazda; A Marciniak-Czochra
Journal:  J Math Biol       Date:  2016-03-03       Impact factor: 2.259

10.  Clonal selection and therapy resistance in acute leukaemias: mathematical modelling explains different proliferation patterns at diagnosis and relapse.

Authors:  Thomas Stiehl; Natalia Baran; Anthony D Ho; Anna Marciniak-Czochra
Journal:  J R Soc Interface       Date:  2014-03-12       Impact factor: 4.118
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.